Fertility preservation in women with malignant and borderline ovarian tumors: Experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG)-Reference-Cited by-同舟云学术

Fertility preservation in women with malignant and borderline ovarian tumors: Experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG)

Published:2021-06 Issue:3 Volume:161 Page:817-824
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Geoffron S.,Lier A.,de Kermadec E.,Sermondade N.,Varinot J.,Thomassin-Naggara I.,Bendifallah S.,Daraï E.,Chabbert-Buffet N.,Kolanska K.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference55 articles.

1. Management of ovarian cancer;Bats;J. Gynecol. Obstet. Biol. Reprod. (Paris),2008

2. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers;Rousset-Jablonski;Eur. J. Cancer,2019

3. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978–1998;Mink;Cancer,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometriosis: Molecular Pathophysiology and Recent Treatment Strategies—Comprehensive Literature Review;Pharmaceuticals;2024-06-24

2. Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-05

3. Safety of assisted reproductive techniques in gynecological cancer patients;Current Opinion in Oncology;2023-07-07

4. Validation of a Salivary miRNA Signature of Endometriosis — Interim Data;NEJM Evidence;2023-06-27

5. MicroRNome analysis generates a blood-based signature for endometriosis;Scientific Reports;2022-03-08